BMS-582949: crystalline form of a p38alpha inhibitor? WO2008079857. (Q45978392)

18 December 2017

title

BMS-582949: crystalline form of a p38alpha inhibitor? WO2008079857. (English)

1 reference

18 December 2017

author name string

Peter Norman

series ordinal

1

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

18 December 2017

Expert Opinion on Therapeutic Patents

published in

1 reference

18 December 2017

volume

19

1 reference

18 December 2017

issue

8

1 reference

18 December 2017

page(s)

1165-1168

1 reference

18 December 2017

Inhibition of p38 MAP kinase as a therapeutic strategy

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

p38 MAPK signalling cascades in inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

Potential adverse effects associated with inhibition of p38alpha/beta MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

A quantitative analysis of kinase inhibitor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

Benzothiazole based inhibitors of p38alpha MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902816160

10.1517/13543770902816160

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017